Natural Killer T Cells Subsets in Cancer, Functional Defects in Prostate Cancer and Implications for Immunotherapy

By Nowak Michael   Schmidt-Wolf Ingo G.H.  

Cancers, Vol. 3, Iss. 3, 2011-09 ,pp. : 3661-3675

MDPI

Access to resources Recommend Favorite

Substantially Modified Ratios of Effector to Regulatory T Cells During Chemotherapy in Ovarian Cancer Patients Return to Pre-Treatment Levels at Completion: Implications for Immunotherapy

By Park Anthony   Govindaraj Chindu   Xiang Sue D.   Halo Julene   Quinn Michael   Scalzo-Inguanti Karen   Plebanski Magdalena  

Cancers, Vol. 4, Iss. 2, 2012-06 ,pp. : 581-600

MDPI

Access to resources Recommend Favorite

Addition of Interleukin-21 for Expansion of T-Cells for Adoptive Immunotherapy of Murine Melanoma

By Zoon Christine Kathryn   Wan Wen   Graham Laura   Bear Harry D.  

International Journal of Molecular Sciences, Vol. 16, Iss. 4, 2015-04 ,pp. : 8744-8760

MDPI

Access to resources Recommend Favorite

Expansion of T Cells with Interleukin-21 for Adoptive Immunotherapy of Murine Mammary Carcinoma

By Zoon Christine K.   Wan Wen   Graham Laura   Bear Harry D.  

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-01 ,pp. : 270-270

MDPI

Access to resources Recommend Favorite

Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners

By Cappello Paola   Curcio Claudia   Mandili Giorgia   Roux Cecilia   Bulfamante Sara   Novelli Francesco  

Cancers, Vol. 10, Iss. 2, 2018-02 ,pp. : 51-51

MDPI

Access to resources Recommend Favorite